CPT code 96913 represents a prolonged photochemotherapy treatment lasting four to eight hours for resistant dermatologic diseases such as psoriasis, eczema, and vitiligo. Nationally, this code captures a specialized, resource-intensive outpatient therapy that combines photosensitizing agents with extended ultraviolet exposure under clinical supervision. Its appropriate use affects access to complex dermatology care and impacts payer coverage policies for prolonged phototherapy services.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of 96913, typical sites of service, and the types of conditions for which the service is indicated. The publication also outlines the common modifiers used with the code and provides benchmarking and policy-relevant considerations where available.

This summary equips clinicians, billing staff, and policy analysts with the essential framing of CPT code 96913—what it represents, why it matters in national coverage and utilization discussions, and what to expect when reviewing payer approaches and reimbursement considerations. Data not available in the input: associated taxonomies, specific ICD-10 diagnoses, related codes, and detailed service-line reporting.